Edesa Biotech, Inc. Common Shares

Go to Edesa Biotech, Inc. Common Shares Website

$2.26

0.00 (0.00%)
Live
Previous Close

$2.26

Day Range

$0 - $0

Previous Day Range

$2.1972 - $2.35

Market Cap

$15.9 million USD

Day Vol.

0

Previous Day Vol.

20890

Currency

USD

Primary Exchange

Nasdaq

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's p...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Dr. Pardeep Nijhawan and Velan Capital have updated their beneficial ownership of securities in Edesa Biotech, Inc. Dr. Nijhawan acquired 100 Series B-1 Convertible Preferred Shares, while Velan Capital acquired 568 Series B-1 Convertible Preferred Shares, both for investment purposes.

Related tickers: EDSA.

Read Full Article

Dr. Pardeep Nijhawan, the CEO of Edesa Biotech, Inc., has acquired beneficial ownership of more than 2% of the company's common shares through a series of transactions and the granting of restricted share units.

Related tickers: EDSA.

Read Full Article
Trending Tickers

Please sign in to view